Functional gastrointestinal disorders and incidence of type 2 diabetes: Evidence from the E3N-EPIC cohort study

Diabetes and Metabolism

Volumn 42, Issue 3, 2016, Pages 178-183

  Fagherazzi, G ^a,b   Gusto, G ^a,b   Balkau, B ^a,b   Boutron Ruault, M C ^a,b   Clavel Chapelon, F ^a,b   Bonnet, F ^a,c  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Cohort; Functional gastrointestinal disorders; Risk factor; Type 2 diabetes

Indexed keywords

LAXATIVE; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BODY MASS; CHRONIC DIARRHEA; COFFEE; COHORT ANALYSIS; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRUIT; GASTROINTESTINAL TRANSIT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RISK FACTOR; VEGETABLE; COMPLICATION; DIABETES MELLITUS, TYPE 2; FRANCE; GASTROINTESTINAL DISEASES; MIDDLE AGED; SCHOOL TEACHER; STATISTICS AND NUMERICAL DATA;

ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FRANCE; GASTROINTESTINAL DISEASES; HUMANS; INCIDENCE; MIDDLE AGED; RISK FACTORS; SCHOOL TEACHERS;

EID: 84953290954     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2015.11.006     Document Type: Article

References (28)

1. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
2. International Diabetes Federation IDF diabetes atlas 2013, International Diabetes Federation, Brussels, Belgium.
3. Suares N.C., Ford A.C. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol 2011, 106:1582-1591.
4. Ho W., Spiegel B.M. The relationship between obesity and functional gastrointestinal disorders: causation, association, or neither?. Gastroenterol Hepatol 2008, 4:572-578.
5. Bommelaer G., Dorval E., Denis P., Czernichow P., Frexinos J., Pelc A., et al. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria. Gastroenterol Clin Biol 2002, 26:1118-1123.
6. Frexinos J., Denis P., Allemand H., Allouche S., Los F., Bonnelye G. Descriptive study of digestive functional symptoms in the French general population. Gastroenterol Clin Biol 1998, 22:785-791.
7. Valdovinos M.A., Camilleri M., Zimmerman B.R. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc 1993, 68:691-702.
8. von der Ohe M.R. Diarrhoea in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995, 7:730-736.
9. Haines S.T. Treating constipation in the patient with diabetes. Diabetes Educ 1995, 21:223-232.
10. Reddy P.M., Dkhar S.A., Subramanian R. Effect of insulin on small intestinal transit in normal mice is independent of blood glucose level. BMC Pharmacol 2006, 6:4.
11. Foss M.T., Clement K.D. Metformin as a cause of late-onset chronic diarrhea. Pharmacotherapy 2001, 21:1422-1424.
12. van Oijen M.G., Josemanders D.F., Laheij R.J., van Rossum L.G., Tan A.C., Jansen J.B. Gastrointestinal disorders and symptoms: does body mass index matter?. Neth J Med 2006, 64:45-49.
13. Delgado-Aros S., Locke G.R., Camilleri M., Talley N.J., Fett S., Zinsmeister A.R., et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol 2004, 99:1801-1806.
14. Talley N.J., Quan C., Jones M.P., Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil 2004, 16:413-419.
15. Talley N.J., Howell S., Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol 2004, 99:1807-1814.
16. Svedberg P., Johansson S., Wallander M.A., Hamelin B., Pedersen N.L. Extra-intestinal manifestations associated with irritable bowel syndrome: a twin study. Aliment Pharmacol Ther 2002, 16:975-983.
17. Aro P., Ronkainen J., Talley N.J., Storskrubb T., Bolling-Sternevald E., Agreus L. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population-based study. Gut 2005, 54:1377-1383.
18. Major G., Spiller R. Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Curr Opin Endocrinol Diabetes Obes 2014, 21:15-21.
19. Jeffery I.B., O'Toole P.W. Diet-microbiota interactions and their implications for healthy living. Nutrients 2013, 5:234-252.
20. Amar J., Serino M., Lange C., Chabo C., Iacovoni J., Mondot S., et al. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 2011, 54:3055-3061.
21. Tremaroli V., Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489:242-249.
22. Fagherazzi G., Vilier A., Bonnet F., Lajous M., Balkau B., Boutron-Rualt M.C., et al. Dietary acid load and risk of type 2 diabetes: the E3N-EPIC cohort study. Diabetologia 2014, 57:313-320.
23. Larsen N., Vogensen F.K., van den Berg F.W., Nielsen D.S., Andreasen A.S., Pedersen B.K., et al. Gut microbiota in human adults with type 2 diabetes differs from nondiabetic adults. PLoS One 2010, 5:e9085.
24. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
25. Esser N., Legrand-Poels S., Piette J., Scheen A.J., Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014, 105(2):141-150.
26. Cani P.D., Osto M., Geurts L., Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012, 3:279-288.
27. Vrieze A., Van N.E., Holleman F., Salojarvi J., Kootte R.S., Bartelsman J.F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143:913-916.
28. Amar J., Chabo C., Waget A., Klopp P., Vachoux C., Bermudez-Humaran L.G., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011, 3:559-572.